Several companies will head to the FDA seeking approval of new Duchenne muscular dystrophy treatments next year but the death of a patient taking Sarepta’s Elevidys raises important safety questions.

This week’s Caller-Times Student of the Week winner is Alyssa Stringer, a senior at Flour Bluff High School. Participating ...

A new and concerning trend in infectious disease has emerged across the U.S., with cases of tularemia — commonly known as ...

Last week, the National Electrical Manufacturers Association (NEMA) announced that U.S. load growth will grow by 2% annually every year until 2050. This annual growth is driven in part by the ...